Dear Recovery Colleagues
After careful consideration given the current COVID-19 pandemic, the Recovery Conference Co-Chairs have rescheduled Recovery of Biological Products XIX (RXIX) in Rome, Italy to July 11-16, 2021. With countries returning to normality and reopening borders, we trust that the new conference dates will enable us to bring the global community in this sector together face-to-face for lively discussion and debate as is the Recovery tradition. Safety and confidence of our attendees are our priority. We are working closely with our suppliers to assure sanitary standards and social distance guidelines.
The theme for RXIX will remain as "Past, Present, Future", and we will aim to highlight past achievements that are part of our foundation, focus on cutting-edge solutions for present challenges and look to build a roadmap together to enable the future.
Given the postponement of the conference by a year, we will be re-opening the call for abstracts in the Fall and repeating the abstract selection process afresh. To be considered for the rescheduled conference dates in 2021, submitters will have the opportunity to either submit completely new abstracts or to update and resubmit their original abstracts.
We thank you for your patience as we plan alternative arrangements for RXIX. And we greatly appreciate the longstanding support of all our sponsors that have helped contribute to the success of the conference series over almost 40 years.
The outbreak has focused the world’s attention on the tremendous contributions that we can make in this sector as well as the urgency for more rapid development of biologics with appropriate regulatory flexibility to facilitate moving at pandemic speed. With this in mind, we are convinced that getting together is more important than ever and so we look forward to your presence at this exciting conference in July 2021.
The RXIX Co-Chairs
Suzy Farid (UCL, UK), Nihal Tugcu (Sanofi, USA), Arne Staby (Novo Nordisk, Denmark)